• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们距离患者端肌钙蛋白检测还有多远?

How Close Are We to Patient-Side Troponin Testing?

作者信息

Goldberg Aaron, McGrath Samuel, Marber Michael

机构信息

Stoke Mandeville Hospital, Aylesbury HP21 8AL, UK.

BHF Centre of Research Excellence, The Rayne Institute, King's College London, 4th Floor, Lambeth Wing, St Thomas' Hospital, London SE1 7EH, UK.

出版信息

J Clin Med. 2024 Dec 12;13(24):7570. doi: 10.3390/jcm13247570.

DOI:10.3390/jcm13247570
PMID:39768493
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11727911/
Abstract

Laboratory-based high-sensitivity cardiac troponin testing has been the pillar for emergency stratification of suspected acute coronary syndrome for well over a decade. Point-of-care troponin assays achieving the requisite analytical sensitivity have recently been developed and could accelerate such assessment. This review summarises the latest assays and describes their potential diverse clinical utility in the emergency department, community healthcare, pre-hospital, and other hospital settings. It outlines the current clinical data but also highlights the evidence gap, particularly the need for clinical trials using whole blood, that must be addressed for safe and successful implementation of point-of-care troponin analysis into daily practice. Additionally, how point-of-care troponin testing can be coupled with advances in biosensor technology, cardiovascular screening, and triage algorithms is discussed.

摘要

十多年来,基于实验室的高敏心肌肌钙蛋白检测一直是疑似急性冠状动脉综合征急诊分层的支柱。最近已开发出达到所需分析灵敏度的即时检测肌钙蛋白检测方法,这可能会加速此类评估。本综述总结了最新的检测方法,并描述了它们在急诊科、社区医疗、院前和其他医院环境中潜在的多种临床用途。它概述了当前的临床数据,但也强调了证据差距,特别是需要进行使用全血的临床试验,这是将即时检测肌钙蛋白分析安全、成功地应用于日常实践所必须解决的问题。此外,还讨论了即时检测肌钙蛋白检测如何与生物传感器技术、心血管筛查和分诊算法的进展相结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92e/11727911/078d94aaeab9/jcm-13-07570-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92e/11727911/078d94aaeab9/jcm-13-07570-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92e/11727911/078d94aaeab9/jcm-13-07570-g001.jpg

相似文献

1
How Close Are We to Patient-Side Troponin Testing?我们距离患者端肌钙蛋白检测还有多远?
J Clin Med. 2024 Dec 12;13(24):7570. doi: 10.3390/jcm13247570.
2
High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.高敏心肌肌钙蛋白检测:从改善分析性能到提高风险分层。
Crit Rev Clin Lab Sci. 2017 May;54(3):143-172. doi: 10.1080/10408363.2017.1285268. Epub 2017 May 1.
3
Diagnostic accuracy of a machine learning algorithm using point-of-care high-sensitivity cardiac troponin I for rapid rule-out of myocardial infarction: a retrospective study.使用即时检测高敏心肌肌钙蛋白I的机器学习算法对心肌梗死进行快速排除诊断的准确性:一项回顾性研究。
Lancet Digit Health. 2024 Oct;6(10):e729-e738. doi: 10.1016/S2589-7500(24)00191-2. Epub 2024 Aug 29.
4
Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain using Point of Care Testing (WESTCOR-POC): study design.旨在使用即时检测(WESTCOR-POC)对胸痛患者的心脏生物标志物进行基于证据的解读(WESTCOR-POC):研究设计。
Scand Cardiovasc J. 2023 Dec;57(1):2272585. doi: 10.1080/14017431.2023.2272585. Epub 2023 Oct 31.
5
Pre-hospital evaluation of chest pain patients using the modified HEART-score: rationale and design.采用改良的 HEART 评分对胸痛患者进行院前评估:原理和设计。
Future Cardiol. 2024 Apr 25;20(5-6):241-250. doi: 10.1080/14796678.2024.2356995. Epub 2024 Jun 28.
6
Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department.临床化学评分与高敏心肌肌钙蛋白 I 和 T 试验单独用于在急诊科就诊时识别低危或高危心肌梗死或死亡的患者。
CMAJ. 2018 Aug 20;190(33):E974-E984. doi: 10.1503/cmaj.180144.
7
Diagnostic accuracy of the Troponin-only Manchester Acute Coronary Syndromes (T-MACS) decision aid with a point-of-care cardiac troponin assay.仅用肌钙蛋白的曼彻斯特急性冠状动脉综合征(T-MACS)决策辅助工具与即时检测心肌肌钙蛋白检测的诊断准确性。
Emerg Med J. 2020 Apr;37(4):223-228. doi: 10.1136/emermed-2019-208882. Epub 2020 Feb 11.
8
External validation of the preHEART score and comparison with current clinical risk scores for prehospital risk assessment in patients with suspected NSTE-ACS.对 preHEART 评分进行外部验证,并与当前临床风险评分进行比较,以评估疑似 NSTE-ACS 患者的院前风险。
Emerg Med J. 2024 Sep 25;41(10):610-616. doi: 10.1136/emermed-2023-213866.
9
Will future troponin measurement overrule the ECG as the primary diagnostic tool in patients with acute coronary syndrome?未来肌钙蛋白检测会取代心电图,成为急性冠脉综合征患者的主要诊断工具吗?
J Electrocardiol. 2013 Jul-Aug;46(4):312-7. doi: 10.1016/j.jelectrocard.2013.02.007. Epub 2013 Mar 13.
10
The usage patterns of cardiac bedside markers employing point-of-care testing for troponin in non-ST-segment elevation acute coronary syndrome: results from CRUSADE.非ST段抬高型急性冠状动脉综合征中采用即时检测肌钙蛋白的心脏床边标志物使用模式:CRUSADE研究结果
Clin Cardiol. 2009 Sep;32(9):498-505. doi: 10.1002/clc.20626.

本文引用的文献

1
Diagnostic accuracy of a machine learning algorithm using point-of-care high-sensitivity cardiac troponin I for rapid rule-out of myocardial infarction: a retrospective study.使用即时检测高敏心肌肌钙蛋白I的机器学习算法对心肌梗死进行快速排除诊断的准确性:一项回顾性研究。
Lancet Digit Health. 2024 Oct;6(10):e729-e738. doi: 10.1016/S2589-7500(24)00191-2. Epub 2024 Aug 29.
2
Analytical verification of the Atellica VTLi point of care high sensitivity troponin I assay.Atellica VTLi即时检验高敏肌钙蛋白I检测法的分析验证
Clin Chem Lab Med. 2024 Aug 28. doi: 10.1515/cclm-2024-0312.
3
Clinical and Analytical Performance of a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay.
新型即时检测高敏心肌肌钙蛋白 I 检测的临床和分析性能。
J Am Coll Cardiol. 2024 Aug 20;84(8):726-740. doi: 10.1016/j.jacc.2024.05.056.
4
External validation of the preHEART score and comparison with current clinical risk scores for prehospital risk assessment in patients with suspected NSTE-ACS.对 preHEART 评分进行外部验证,并与当前临床风险评分进行比较,以评估疑似 NSTE-ACS 患者的院前风险。
Emerg Med J. 2024 Sep 25;41(10):610-616. doi: 10.1136/emermed-2023-213866.
5
Diagnostic Performance of Point-of-Care High-Sensitivity Troponin in the Exclusion of Non-ST-Elevation Myocardial Infarction in the Emergency Department.即时检测高敏肌钙蛋白在急诊科排除非ST段抬高型心肌梗死中的诊断性能
J Pers Med. 2024 Jul 17;14(7):762. doi: 10.3390/jpm14070762.
6
Protocol for Improving Care by FAster risk-STratification through use of high sensitivity point-of-care troponin in patients presenting with possible acute coronary syndrome in the EmeRgency department (ICare-FASTER): a stepped-wedge cluster randomised quality improvement initiative.通过在急诊科对疑似急性冠状动脉综合征患者使用高敏即时检测肌钙蛋白进行更快风险分层来改善护理的方案(ICare-FASTER):一项阶梯式楔形整群随机质量改进倡议。
BMJ Open. 2024 Jun 13;14(6):e083752. doi: 10.1136/bmjopen-2023-083752.
7
Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h.在疑似急性心肌梗死患者中,于基线和 2 小时时进行即时检测高敏心肌肌钙蛋白评估。
Eur Heart J. 2024 Jul 21;45(28):2508-2515. doi: 10.1093/eurheartj/ehae343.
8
Diagnostic performance of a point of care high-sensitivity cardiac troponin I assay and single measurement evaluation to rule out and rule in acute coronary syndrome.即时检测高敏心肌肌钙蛋白I检测法对急性冠状动脉综合征的排除和诊断性能及单次测量评估
Clin Chem Lab Med. 2024 Apr 29;62(11):2326-2334. doi: 10.1515/cclm-2024-0225. Print 2024 Oct 28.
9
Evaluating the performance of the HEART score in a Tanzanian emergency department.评估 HEART 评分在坦桑尼亚急诊科的表现。
Acad Emerg Med. 2024 Apr;31(4):361-370. doi: 10.1111/acem.14872. Epub 2024 Feb 23.
10
Pre-hospital rule-out of non-ST-segment elevation acute coronary syndrome by a single troponin: final one-year outcomes of the ARTICA randomised trial.通过单次肌钙蛋白检测在院前排除非ST段抬高型急性冠状动脉综合征:ARTICA随机试验的一年最终结果
Eur Heart J Qual Care Clin Outcomes. 2024 Aug 8;10(5):411-420. doi: 10.1093/ehjqcco/qcae004.